Introduction
Metabolic syndrome is characterized by abdominal obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, high blood pressure, and high fasting glucose level (1) (2) (3) (4) . Recent studies have found that metabolic syndrome is associated with an increased risk for cardiovascular disease (5, 6) . There are several definitions of metabolic syndrome (1) (2) (3) (4) 
. The definition by the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III;based on 5 commonly measured clinical indices, while the definition proposed by the International Diabetes Federation (IDF) (3) and the Japanese definition (4) were based on the precondition of the presence of abdominal obesity.
Along with the recognition of metabolic syndrome as a risk factor for cardiovascular disease (5, 6) , urinary albumin excretion, a marker of endothelial dysfunction, and highsensitivity C reactive protein (CRP), a sensitive marker of low-grade inflammation, have been found to predict future cardiovascular events (7, 8) . Furthermore, chronic kidney disease has been recognized as a risk factor for cardiovascular disease as well as end-stage renal disease (9, 10) . To date, several lines of study have investigated the association of metabolic syndrome with urinary albumin excretion, high-sensitivity CRP, or chronic kidney disease (11) (12) (13) (14) (15) (16) ; however, to the best of our knowledge, no studies have investigated the association of metabolic syndrome with these 3 factors together in the same individual. Therefore, we conducted the present study to obtain more information and enrolled a population of Japanese subjects without diabetes, macroalbuminuria, or medications.
Methods

Study population
The Institutional Committee of our hospital approved the study and written informed consent was obtained from each participant. A total of 712 Japanese subjects ( (18) .
Definitions of metabolic syndrome
The present study adopted the 4 Blood Cholesterol in Adults; AHA/NHLBI, the American Heart Association and the National Heart, Lung, and Blood Institute; IDF, the (Fig. 1) , whereas estimated GFR and the prevalence of low GFR did not differ significantly between those with and without metabolic syndrome, irrespective of the definition (Fig. 2) high-sensitivity C-reactive protein; GFR, glomerular filtration rate.
F i g u r e 1 . Ur i n a r y a l b u mi n e x c r e t i o n ( p a n e l A) a n d h i g h -s e n s i t i v i t y CRP ( p a n e l B ) i n t h o s e wi t h ( + ) a n d wi t h o u t ( -) me t a b o l i c s y n d r o me ( Me t S ) d i a g n o s e d b y t h e 4 d e f i n i t i o n s . Na t u r a l l o g a r i t h mt r a n s f o r me d v a l u e s we r e u s e d i n t h e a n a l y s i s .
Logistic regression analysis in model 1 revealed that among the 5 components of metabolic syndrome, only systolic blood pressure was an independent determinant of low GFR (Table 4). Logistic regression analysis in model 2 revealed that age and systolic blood pressure were independent determinants of low GFR. Logistic regression analysis in model 3 revealed that age and drinking were independent determinants of low GFR. In models 4-7, only age was an independent determinant of low GFR, while metabolic syndrome was not.
Discussion
Albuminuria is an established marker of underlying vascular dysfunction (20). Although the traditional upper limit of normal daily albumin excretion has been 30 mg/day, recent epidemiological data suggested that levels in the general population are actually much lower (20). Further, within this range of low-grade albuminuria, increasing excretion rates are associated with an increased risk of cardiovascular disease independent of renal function (20). In the present study, urinary albumin excretion was within the range of
F i g u r e 2 . T h e e s t i ma t e d g l o me r u l a r f i l t r a t i o n r a t e ( e GF R) ( p a n e l A) a n d t h e p r e v a l e n c e o f l o w g l o me r u l a r f i l t r a t i o n r a t e ( GF R) ( p a n e l B ) i n t h o s e wi t h ( + ) a n d wi t h o u t ( -) me t a b o l i c s y n d r o me ( Me t S ) d i a g n o s e d b y t h e 4 d e f i n i t i o n s .
T a b l e 2 . Mu l t i p l e Re g r e s s i o n An a l y s i s f o r I n d e p e n d e n t Va r i a b l e s As s o c i a t e d wi t h Ur i n a r y Al b u mi n E x c r e t i o n ( n = 7 1 2 )
With regard to urinary albumin excretion and hsCRP, natural logarithm-transformed values were used in the analysis. Blood Cholesterol in Adults; AHA/NHLBI, the American Heart Association and the National Heart, Lung, and Blood Institute; IDF, the International Diabetes Federation; β, standardized regression coefficient, SBP, systolic blood pressure; TG, triglycerides; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; FPG, fasting plasma glucose; MetS, metabolic syndrome; UAE, urinary albumin excretion; GFR, glomerular filtration rate.
low-grade albuminuria in the majority of the participants (96.8%). We found that urinary albumin excretion was significantly higher in subjects with metabolic syndrome than without, confirming a number of earlier observations (11, 12). In the present study, however, among the 5 components of metabolic syndrome and other clinical variables, only systolic blood pressure was independently associated with urinary albumin excretion. It is well recognized that an in-T a b l e 3 . Mu l t i p l e Re g r e s s i o n An a l y s i s f o r Va r i a b l e s As s o c i a t e d wi t h Hi g h -S e n s i t i v i t y C-Re a c t i v e P r o t e i n ( n = 7 1 2 )
With regard to high-sensitivity C-reactive protein and UAE, natural logarithm-transformed values were used in the analysis.
T a b l e 4 . L o g i s t i c Re g r e s s i o n An a l y s i s f o r Va r i a b l e s As s o c i a t e d wi t h L o w GF R ( n = 7 1 2 )
Model 1 (13, 14) . Also in the present study, high-sensitivity CRP was significantly higher in subjects with metabolic syndrome than without, irrespective of the definition of metabolic syndrome; more notably, the 5 components of metabolic syndrome as well as LDL cholesterol were all independent determinants of high-sensitivity CRP, verifying the view that low-grade inflammation is closely associated with metabolic syndrome and its components (13, 14) .
In (21) and also with several previous reports by other researchers (22) . Furthermore, in multiple regression analysis, smoking was a positive determinant of high-sensitivity CRP, whereas drinking was a negative determinant. The former finding confirms previous reports, including ours (23) , that high-sensitivity CRP is higher in smokers than in nonsmokers. The latter also verifies previous observations that light-to-moderate drinking has an anti-inflammatory action (24) .
We 
